Disappearance of a growth hormone secreting macro adenoma during long-term somatostatin analogue administration and recurrence following somatostatin withdrawal Posted on by Read More
Growth hormone binding protein and acid labile subunit levels in the assessment of acromegaly treatment Posted on by Read More
Diagnostic features and outcome of surgical therapy of acromegalic patients: Experience of the last three decades Posted on by Read More
Beneficial effect of dose escalation and surgical debulking in patients with acromegaly treated with somatostatin analogs in a Romanian tertiary care center Posted on by Read More
Therapeutic trends and outcome of acromegaly: a single center experience over a 40-year period Posted on by Read More
Somatotropinomas inadequately controlled with octreotide may over-respond to pasireotide: the importance of dose adjustment to achieve long-term biochemical control Posted on by Read More